BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12714908)

  • 1. [Therapeutic possibilities for polyomavirus infections in renal transplantation].
    Hurault de Ligny B; Godin M; Lobbedez T; Etienne I; El Haggan W; Pujo M; Ryckelynck JP
    Presse Med; 2003 Apr; 32(14):667-8. PubMed ID: 12714908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BK transplant nephropathy successfully treated with cidofovir.
    Keller LS; Peh CA; Nolan J; Bannister KM; Clarkson AR; Faull RJ
    Nephrol Dial Transplant; 2003 May; 18(5):1013-4. PubMed ID: 12686681
    [No Abstract]   [Full Text] [Related]  

  • 3. Treatment of polyomavirus infection with cidofovir in a renal-transplant recipient.
    Bjorang O; Tveitan H; Midtvedt K; Broch LU; Scott H; Andresen PA
    Nephrol Dial Transplant; 2002 Nov; 17(11):2023-5. PubMed ID: 12401867
    [No Abstract]   [Full Text] [Related]  

  • 4. [Diagnosis of interstitial nephropathy caused by BK virus in renal transplantation. Therapeutic management with cidofovir plus probenecid].
    Barrios C; Puig JM; Mir ML
    Nefrologia; 2007; 27(6):774-5. PubMed ID: 18336115
    [No Abstract]   [Full Text] [Related]  

  • 5. BK nephropathy: what is the role of antiviral therapy?
    Fishman JA
    Am J Transplant; 2003 Feb; 3(2):99-100. PubMed ID: 12614295
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical aspects of human polyomaviruses in renal transplantation].
    Hurault de Ligny B; Francois A; Lobbedez T; Comoz F; Etienne I; El Haggan W; Pujo M; Godin M; Ryckelynck JP
    Presse Med; 2003 Apr; 32(14):659-66. PubMed ID: 12714907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of cidofovir in polyomavirus BK viral nephropathy in two renal allograft recipients.
    Lim WH; Mathew TH; Cooper JE; Bowden S; Russ GR
    Nephrology (Carlton); 2003 Dec; 8(6):318-23. PubMed ID: 15012704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of refractory BK virus-associated nephropathy with cidofovir.
    Kadambi PV; Josephson MA; Williams J; Corey L; Jerome KR; Meehan SM; Limaye AP
    Am J Transplant; 2003 Feb; 3(2):186-91. PubMed ID: 12614296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single-centre study of adjuvant cidofovir therapy for BK virus interstitial nephritis (BKVIN) in renal allograft recipients.
    Kuypers DR; Bammens B; Claes K; Evenepoel P; Lerut E; Vanrenterghem Y
    J Antimicrob Chemother; 2009 Feb; 63(2):417-9. PubMed ID: 19056749
    [No Abstract]   [Full Text] [Related]  

  • 10. Intermediate-dose cidofovir without probenecid in the treatment of BK virus allograft nephropathy.
    Araya CE; Lew JF; Fennell RS; Neiberger RE; Dharnidharka VR
    Pediatr Transplant; 2006 Feb; 10(1):32-7. PubMed ID: 16499584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BK virus-associated nephropathy].
    Kaltenis P
    Medicina (Kaunas); 2003; 39(7):637-9. PubMed ID: 12878816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BK virus nephritis after renal transplantation.
    Hariharan S
    Kidney Int; 2006 Feb; 69(4):655-62. PubMed ID: 16395271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults.
    Vats A; Shapiro R; Singh Randhawa P; Scantlebury V; Tuzuner A; Saxena M; Moritz ML; Beattie TJ; Gonwa T; Green MD; Ellis D
    Transplantation; 2003 Jan; 75(1):105-12. PubMed ID: 12544881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of BK virus-associated nephropathy with Cidofovir in renal transplantation.
    Cabello V; Margarit N; Díaz Pedrero M; Bernal G; Pereira P; Gentil MA
    Transplant Proc; 2008 Nov; 40(9):2930-2. PubMed ID: 19010151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A single-center experience with BK virus nephropathy.
    Ott U; Steiner T; Busch M; Gerth J; Wolf G
    Clin Nephrol; 2008 Apr; 69(4):244-50. PubMed ID: 18397698
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant low-dose cidofovir therapy for BK polyomavirus interstitial nephritis in renal transplant recipients.
    Kuypers DR; Vandooren AK; Lerut E; Evenepoel P; Claes K; Snoeck R; Naesens L; Vanrenterghem Y
    Am J Transplant; 2005 Aug; 5(8):1997-2004. PubMed ID: 15996251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Observations on the use of cidofovir for BK virus infection in renal transplantation.
    Kuten SA; Patel SJ; Knight RJ; Gaber LW; DeVos JM; Gaber AO
    Transpl Infect Dis; 2014 Dec; 16(6):975-83. PubMed ID: 25412701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polyomavirus BK.
    Hirsch HH; Steiger J
    Lancet Infect Dis; 2003 Oct; 3(10):611-23. PubMed ID: 14522260
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BK virus nephropathy diagnosis and treatment: experience at the University of Maryland Renal Transplant Program.
    Ramos E; Drachenberg CB; Portocarrero M; Wali R; Klassen DK; Fink JC; Farney A; Hirsch H; Papadimitriou JC; Cangro CB; Weir MR; Bartlett ST
    Clin Transpl; 2002; ():143-53. PubMed ID: 12971444
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of cidofovir treatment of polyomavirus nephropathy in kidney transplant recipients.
    Hua DK; Howard K; Craig JC; Chapman JR; Wong G
    Transplantation; 2012 Jan; 93(2):188-94. PubMed ID: 22186937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.